Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders. (Q47920400)

6 February 2018

title

Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders. (English)

1 reference

6 February 2018

1 reference

12

Olav Spigset

1 reference

6 February 2018

10

Ingrid Melle

1 reference

PubMed ID

27712130

6 February 2018

Erlend Strand Gardsjord

7

object named as

Erlend Gardsjord

1 reference

6 February 2018

9

Ingrid Agartz

1 reference

6 February 2018

13

Ole A Andreassen

1 reference

6 February 2018

11

Torill Ueland

1 reference

6 February 2018

author name string

Nils Eiel Steen

1

1 reference

6 February 2018

Monica Aas

2

1 reference

6 February 2018

Carmen Simonsen

3

1 reference

6 February 2018

Ingrid Dieset

4

1 reference

6 February 2018

Martin Tesli

5

1 reference

6 February 2018

Mari Nerhus

6

1 reference

6 February 2018

Ragni Mørch

8

1 reference

6 February 2018

publication date

7 October 2016

1 reference

6 February 2018

World Journal of Biological Psychiatry

published in

1 reference

6 February 2018

volume

18

1 reference

6 February 2018

page(s)

471-482

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

A 2-year naturalistic study on cognitive functioning in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Systolic blood pressure reactions to acute stress are associated with future hypertension status in the Dutch Famine Birth Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Does level of care, sex, age, or choice of drug influence adherence to treatment with antipsychotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Inverted-U-shaped dopamine actions on human working memory and cognitive control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Working memory capacity predicts dopamine synthesis capacity in the human striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

The role of dopamine in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Current smoking is associated with worse cognitive and adaptive functioning in serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

A systematic review and meta-analysis of exercise interventions in schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Antipsychotic medication and cognitive function in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

High-dose of multiple antipsychotics and cognitive function in schizophrenia: the effect of dose-reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Aripiprazole: pharmacology, efficacy, safety and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Processing speed deficits in schizophrenia: reexamining the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: a [11C]FLB 457 PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Doubtful association of antipsychotic polypharmacy and high dosage with cognition in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Assessing and treating cognitive impairment in schizophrenia: current and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Striatal dopamine release during performance of executive functions: A [(11)C] raclopride PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Psychomotor and memory effects of haloperidol, olanzapine, and paroxetine in healthy subjects after short-term administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Second-generation antipsychotic effect on cognition in patients with schizophrenia--a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Generalizability studies of the Global Assessment of Functioning-Split version.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Gone to Pot - A Review of the Association between Cannabis and Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Effect of aripiprazole on cognition in the treatment of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Pharmacogenetics of olanzapine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Increased systemic cortisol metabolism in patients with schizophrenia and bipolar disorder: a mechanism for increased stress vulnerability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

PET neuroimaging of extrastriatal dopamine receptors and prefrontal cortex functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

Attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1245441

10.1080/15622975.2016.1245441

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

27712130

1 reference

6 February 2018